Sep 2026· International ophtalmology· Vol 46· 0 citations· 37 references
Medicine
TL;DR
AOSWSD protects ARPE−19 cells from high glucose-induced injury through simultaneous, dose-dependent modulation of oxidative stress, inflammation, apoptosis and angiogenic signaling, with the VEGFA/VEGFR2–PI3K/AKT/mTOR cascade acting as a principal molecular substrate.
The protective effects of SCU are significantly associated with the restoration of AQP4/Kir4.1 homeostasis and the suppression of the TLR4/MyD88/NF-κB/VEGFA pathway, suggesting its potential as a multi-target candidate drug for delaying the progression of DR.
Yun-Hua Tang, Shan Ding, Wen-Yan Peng et al.· Frontiers in Pharmacology· 0 citations
It is demonstrated that HWMMT exerts neuroprotection in early DR by suppressing the IL-1β/c-Jun signaling cascade and restoring GS expression and function in Müller cells, thereby reducing extracellular glutamate accumulation and mitigating excitotoxic damage.
Xue-Wei Qin, Li-Min Wang, Xian-Feng Yao et al.· In vitro Cellular & Developm...· 0 citations
ETHNOPHARMACOLOGICAL RELEVANCE
Alpinia oxyphylla Miq., referred to in Chinese as Yi Zhi Ren (YZR), is a traditional Chinese herbal medicine long used to treat stroke. However, the effects of YZR extract on angiogenesis in subacute ischemic stroke remain unclear.
AIM OF THE STUDY
The effects of YZR extract administere...
Tin-Yun Ho, Chien-Yun Hsiang, Ngoc-Thac Pham et al.· Journal of Ethnopharmacology· 0 citations
BACKGROUND
Cerebral ischemia-reperfusion injury (CIRI) remains a major barrier to neurological recovery after ischemic stroke, and effective pharmacological interventions targeting upstream neurovascular unit mechanisms related to ferroptosis and blood-brain barrier (BBB) injury are limited.
PURPOSE
This study aimed...
Jiang-Ming Zhu, Ju Ye, Liu-Qin Zhao et al.· Phytomedicine· 0 citations
Paeoniflorin alleviated CIRI by directly protecting neurons and indirectly modulating neuron–endothelial crosstalk through VEGF/PI3K-AKT/mTOR activation, supporting its multi-target therapeutic potential.
Zi-Shuo Xu, Hong Luo, Yi-Ming Zhao et al.· Pharmaceuticals· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.